Overview

N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure

Status:
Unknown status
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Treatment with n-acetylcysteine in patients with heart failure and chronic renal failure leads to improvements in vascular function and in renal function.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bayside Health
Collaborator:
The Alfred
Treatments:
Acetylcysteine
N-monoacetylcystine